Effects of Magnolol combined with Gefitinib on A549 non-small cell lung cancer cells.
10.12047/j.cjap.6138.2021.076
- Author:
Ji-Lian REN
1
;
Ling-Zhi CUI
2
;
Xiao-Xia HAO
1
;
Xiao-Yan LI
3
;
Yan-Xiang CHANG
4
Author Information
1. Department of Medical Laboratory, Fenyang College, Shanxi Medical University, Fenyang 032200.
2. Department of Cadre Diagnosis and Treatment, Shanxi Cancer Hospital, Taiyuan 030013.
3. Department of Laboratory Medicine, Fenyang Hospital, Shanxi Province, Fenyang 032200.
4. The First Affiliated Hospital of Xi'an Medical College, Xi'an 710077, China.
- Publication Type:Journal Article
- Keywords:
Gefitinib;
magnolol;
non-small cell lung cancer A549 cells;
stem cell like characteristics
- MeSH:
A549 Cells;
Apoptosis;
Biphenyl Compounds/pharmacology*;
Carcinoma, Non-Small-Cell Lung/pathology*;
Cell Line, Tumor;
Cell Proliferation;
Gefitinib/pharmacology*;
Humans;
Lignans/pharmacology*;
Lung Neoplasms/pathology*
- From:
Chinese Journal of Applied Physiology
2021;37(5):506-510
- CountryChina
- Language:Chinese
